By 2010, liraglutide (under the brand name Victoza) was approved for type 2 diabetes, becoming the first long-acting GLP-1 analog in the world
Recently, multiparametric MRI, such as LiverMultiScan, has gained attention for assessment of necroinflammation and shows promise in this area, although more confirmatory data is needed.40 Biomarker assessment of fibrosis is still limited as we are unable to provide a precise assessment of the directionality of fibrosis over time, because of the dynamic balance between fibrogenesis and fibrinolysis
Wegovy side effects are often most noticeable: during the first days or weeks of treatment after increasing the dose when restarting treatment Digestive side effects such as nausea, vomiting, diarrhea, constipation, and stomach pain are usually more common early in treatment and may improve over time
Randomized participants follow an 8-week dose escalation regimen (3 mg [weeks 04], 7 mg [weeks 48], and 14 mg [weeks 8156])
The lawsuit claims a 44-year-old woman with a history of diabetes took Ozempic for over one year, stopping in July, at which point she started using Mounjaro
